Pricing Log in Create free account
Friday 6 November 2026 Export RVTY’s income statement to Excel — free account

Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024.

Revenue
+4.29%
EPS
+2.17%
Free cash flow
+27.0%
Total debt
−18.1%

Quarter to September 2026, against a year earlier

150.97 8.46 −5.31%
Market cap
$16.8B
P/E
71.9×
Fwd P/E
66.2×
Dividend yield
0.19%
F-score
6/9
Altman Z
2.49
Beneish M
−2.45
Dividend safety
80/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Revvity Inc. (RVTY) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Nov 3, 2026 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jul 5, 2026 P1I2: 8 added · 1 removed · 26 modified
P2I1A: 5 modified
8-K Aug 4, 2026 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Apr 5, 2026
8-K May 5, 2026 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Apr 28, 2026 5.03 Amendments to the articles or bylaws; change in fiscal year; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
10-K Dec 28, 2025 1: 41 added · 15 removed · 74 modified
1A: 4 added · 1 removed · 19 modified
7: 13 added · 32 removed · 18 modified
8-K Feb 2, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 12, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure
10-Q Sep 28, 2025
8-K Oct 27, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 23, 2025 5.02 Departure or appointment of directors or officers Officer departure
10-Q Jun 29, 2025
8-K Jul 28, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 30, 2025
8-K Apr 28, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 29, 2024
8-K Jan 31, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 12, 2025 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure
10-Q Sep 29, 2024
8-K Nov 4, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Jul 29, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 29, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 1, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 9, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.